In Brief Brian Druker, developer of Gleevec, crosses Boston Marathon finish line alongside daughter Julia May 02, 2025Vol.51 No.17
Funding Opportunities AACR establishes grant program to support early-stage and mid-career cancer researchers May 02, 2025Vol.51 No.17
Clinical Roundup Sotorasib + panitumumab offers better outcomes in colorectal cancer that no longer responds to treatment May 02, 2025Vol.51 No.17
Clinical Roundup Sasanlimab combination significantly improves EFS in BCG-naïve, high-risk non-muscle invasive bladder cancer May 02, 2025Vol.51 No.17
Clinical Roundup Pembro + standard-of-care improves survival in locally advanced head-and-neck cancer May 02, 2025Vol.51 No.17
Clinical Roundup TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in certain bladder cancers May 02, 2025Vol.51 No.17
Clinical Roundup Zongertinib demonstrates clinical benefit in advanced HER2-mutated lung cancer May 02, 2025Vol.51 No.17
Clinical Roundup UC Lung Cancer Consortium and AstraZeneca partner to improve early lung cancer detection May 02, 2025Vol.51 No.17
Clinical Roundup USC team develops analytical tool to advance CAR T-cell therapy research May 02, 2025Vol.51 No.17
Clinical Roundup High cannabis use linked to increased mortality in colon cancer patients May 02, 2025Vol.51 No.17
